![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-01-02 Sale | 2020-01-03 4:06 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 2,239 | $0.9667 | $2,164 | 29,307 (Direct) | View |
2020-01-02 Sale | 2020-01-03 4:07 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 8,345 | $0.9667 | $8,067 | 235,083 (Direct) | View |
2020-02-18 Sale | 2020-02-19 6:08 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 888 | $0.8305 | $737 | 28,419 (Direct) | View |
2020-02-18 Sale | 2020-02-19 6:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,324 | $0.8304 | $3,591 | 230,759 (Direct) | View |
2020-05-15 Sale | 2020-05-18 4:27 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 909 | $0.6268 | $570 | 27,510 (Direct) | View |
2020-05-15 Sale | 2020-05-18 4:28 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,426 | $0.6267 | $2,774 | 226,333 (Direct) | View |
2020-08-14 Sale | 2020-08-17 8:21 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 872 | $0.605 | $528 | 26,638 (Direct) | View |
2020-08-14 Sale | 2020-08-17 8:22 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,245 | $0.6049 | $2,568 | 222,088 (Direct) | View |
2020-11-16 Sale | 2020-11-18 4:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 6,094 | $0.5211 | $3,176 | 215,994 (Direct) | View |
2020-11-16 Sale | 2020-11-18 4:10 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 876 | $0.5211 | $456 | 25,762 (Direct) | View |
2020-12-04 Purchase | 2020-12-07 5:06 pm | Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Direct) | View |
2020-12-04 Purchase | 2020-12-07 5:08 pm | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:09 pm | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:11 pm | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:13 pm | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:14 pm | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-12-24 Purchase | 2019-12-26 5:02 pm | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 9,009,000 | $0.125 | 900,900 (Indirect) | View |
2019-12-24 Purchase | 2019-12-26 5:02 pm | 2019-12-24 N/A | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 900,900 | $6.66 | 900,900 (Indirect) | View |
2019-12-24 Purchase | 2019-12-26 5:03 pm | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 9,009,000 | $0.125 | 900,900 (Indirect) | View |
2019-12-24 Purchase | 2019-12-26 5:03 pm | 2019-12-24 N/A | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 900,900 | $6.66 | 900,900 (Indirect) | View |
2019-12-24 Purchase | 2020-01-03 9:53 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP 10% Owner | 423,162 | $0.666 | 6,083,471 (Indirect) | View |
2019-12-24 Purchase | 2020-01-03 9:53 pm | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP 10% Owner | 4,231,620 | $6.66 | 6,083,471 (Indirect) | View |
2020-01-22 Option Award | 2020-01-24 4:11 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 210,000 | $1.31 | 210,000 (Direct) | View |
2020-01-22 Option Award | 2020-01-24 4:12 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA CFO | 150,000 | $1.31 | 150,000 (Direct) | View |
2020-01-22 Option Award | 2020-01-24 4:13 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 900,000 | $1.31 | 900,000 (Direct) | View |
2020-02-03 Conversion | 2020-02-04 4:59 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 846,320 | $0 | 0 (Direct) | View |
2020-02-03 Conversion | 2020-02-04 4:59 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 84,632 | $0 | 0 (Direct) | View |
2020-02-03 Conversion | 2020-02-04 5:05 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 225,940 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-04 5:05 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 22,594 | $0 | 0 (Indirect) | View |
2020-04-01 Other | 2020-05-08 8:03 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Sarissa Capital Offshore Master Fund LP 10% Owner | 5,311 | $0 | 2,627,037 (Direct) | View |
2020-04-01 Other | 2020-05-08 8:03 pm | 2020-04-01 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Sarissa Capital Offshore Master Fund LP 10% Owner | 23,243 | $1.08 | 2,627,037 (Direct) | View |
2020-04-01 Other | 2020-05-08 8:03 pm | 2020-04-01 2024-12-24 | Regulus Therapeutics Inc. | RGLS | Sarissa Capital Offshore Master Fund LP 10% Owner | 53,113 | $0.666 | 2,627,037 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:37 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:38 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:39 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:40 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:42 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 23,250 | $0.88 | 23,250 (Indirect) | View |
2020-06-17 Option Award | 2020-06-19 4:43 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:44 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-06-17 Option Award | 2020-06-19 4:45 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 23,250 | $0.88 | 23,250 (Direct) | View |
2020-08-03 Option Award | 2020-08-05 09:12 am | N/A 2030-08-02 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 300,000 | $0.6879 | 300,000 (Direct) | View |
2020-12-04 Option Award | 2020-12-07 4:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 595,146 (Direct) | View |
2020-12-04 Option Award | 2020-12-07 4:21 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 595,146 | $0.125 | 595,146 (Direct) | View |
2020-12-04 Option Award | 2020-12-07 4:22 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 39,680 | $0.6301 | 29,760 (Indirect) | View |
2020-12-04 Option Award | 2020-12-07 4:22 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 29,760 | $0.125 | 29,760 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:06 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Direct) | View |
2020-12-04 Purchase | 2020-12-07 5:06 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 258,707 | $6.22 | 6,451,056 (Direct) | View |
2020-12-04 Purchase | 2020-12-07 5:08 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:08 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:09 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:09 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:11 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:11 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:13 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:13 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:14 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 5,239,254 | $0.125 | 6,451,056 (Indirect) | View |
2020-12-04 Purchase | 2020-12-07 5:14 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 258,707 | $6.22 | 6,451,056 (Indirect) | View |